Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-08-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
独立董事关于第五届董事会第十一次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on related party transactions and management agreements concerning the company's board meeting. It discusses the fairness, legality, and approval process of these transactions and agreements, referencing regulatory guidelines and company bylaws. The document does not contain financial statements or detailed financial performance data but rather provides governance-related opinions and approvals on specific corporate actions. It is not an annual report, audit report, earnings release, or any financial report. It is also not a simple announcement but a formal opinion related to board matters and governance. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the company's board or senior management activities.
2021-08-09 Chinese
长春盈康医院有限公司2021年1-6 月审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for 长春盈康医院有限公司 covering the period January to June 2021. It includes detailed financial statements such as the balance sheet, income statement, cash flow statement, statement of changes in equity, and extensive notes on accounting policies and estimates. The presence of an auditor's opinion from a certified public accounting firm (信永中和会计师事务所) and detailed audit responsibilities confirms this is a standalone audit report. The document is comprehensive and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). H1 2021
2021-08-09 Chinese
杭州怡康中医肿瘤医院有限公司2021年1-6 月审计报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as an "审计报告" (Audit Report) for the period January to June 2021 of 杭州怡康中医肿瘤医院有限公司. It contains detailed financial statements including balance sheet, income statement, cash flow statement, statement of changes in equity, and extensive notes on accounting policies and financial details. The report is signed by a certified public accounting firm and includes an auditor's opinion on the fairness of the financial statements. The content is comprehensive and includes actual financial data and analysis for a half-year period. This matches the definition of an Interim / Quarterly Report (IR), as it is a comprehensive financial report for a period shorter than a full fiscal year with substantive financial data and analysis. Although it is called an audit report, it is not a standalone audit report but includes full financial statements and notes for the interim period. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2021
2021-08-09 Chinese
第五届监事会第十一次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th (extraordinary) meeting of the 5th Supervisory Board of Yingkang Life Technology Co., Ltd. It details the meeting's attendance, the approval of several related-party transactions including the sale of hospital equity and related debt, and the approval of audit and asset appraisal reports related to these transactions. The document also mentions that these matters will be submitted to the shareholders' meeting for further approval. The content is focused on board-level decisions and supervisory board resolutions rather than full financial reports or earnings. It is not a full audit report, annual report, or earnings release, but rather a governance-related announcement about board resolutions and approvals. Therefore, the best fitting category is Board/Management Information (MANG). The document length is 2761 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report.
2021-08-09 Chinese
独立董事关于第五届董事会第十一次（临时）会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of related party transactions and agreements to be considered at a specific board meeting (the 11th temporary meeting of the 5th board). It discusses the fairness and compliance of transactions involving sale of subsidiaries' equity and related debts to the controlling shareholder, and the signing of a management entrustment agreement. The document is not a financial report, earnings release, or regulatory filing per se, but rather a board/management related announcement concerning governance and approval of significant corporate actions. It does not contain financial statements or earnings data, nor is it a notice of voting results or a proxy solicitation. The content fits best under Board/Management Information (MANG) as it relates to board meeting matters and approvals by independent directors.
2021-08-09 Chinese
盈康生命科技股份有限公司拟剥离资产涉及的长春盈康医院有限公司股东全部权益价值项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an "资产评估报告" (Asset Appraisal Report) and is prepared according to Chinese asset appraisal standards. It is a detailed valuation report for the shareholder equity of Changchun Yingkang Hospital Co., Ltd., commissioned by Yingkang Life Technology Co., Ltd. The report includes asset and liability details, valuation methods (asset-based and income approach), audit references, and financial data as of June 30, 2021. It is a comprehensive standalone asset valuation report, not an announcement or summary. This fits the definition of an Audit Report / Information (AR), which includes applied accounting principles and valuation results but is distinct from a full Annual Report or Interim Report. The document is about asset valuation related to a proposed asset divestiture, which is typical for an AR filing rather than a capital update or M&A filing. The length and detail confirm it is a full report, not a brief announcement or certification. H1 2021
2021-08-09 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.